CCL5 and neoplasm: K–M analysis revealed a significant association between chemotherapy response and CCL5-negative ICs for the tumor stage subgroup pT3 + 4 in terms of the mean OS (p = 0.015), mean DSS (p = 0.039), and mean RFS (p = 0.044) (Table 6 and Figure 4).